Read this commentary from Ritu Salani, MD, MBA, with her thoughts on recent advances and approvals for immunotherapy-based combinations and targeted therapies in cervical cancer.
In this commentary, Kathleen Moore, MD, discusses new approaches and new agents that may meaningfully improve outcomes for women with platinum-resistant ovarian cancer.
Review this expert analysis by Ritu Salani, MD, MBA, and Eva Y. Pan, PharmD, BCOP, focusing on the most recent practice-changing evidence for patients with ovarian, endometrial, and cervical cancers.
Download this slideset associated with the online text module on gynecologic cancer advances, in which experts Ritu Salani, MD, MBA, and Eva Y. Pan, PharmD, BCOP, discuss the best strategies for optimizing management approaches for patients with ovarian, endometrial, and cervical cancers.
Use this Interactive Decision Support Tool to compare your management of patients with ovarian cancer with those of 5 renowned gynecologic oncology experts.